Table 1. The HTRA1 polymorphisms identified in PCV subjects.
Polymorphism | db SNP ID | Codon change | Genotypic Frequencies |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PCV (n = 188) | AMD (n = 195) | Control (n = 183) | pG | pA | |||||||||
−625G>A | rs11200638 | – | 70 | 84 | 33 | 109 | 63 | 23 | 38 | 90 | 55 | 1.00 × 10−4 | 7.49 × 10−4 |
−502C>T | Reported | – | 0 | 15 | 173 | 0 | 14 | 181 | 0 | 20 | 163 | 0.33 | 0.34 |
−497C>T | Reported | – | 0 | 7 | 181 | 0 | 6 | 189 | 0 | 8 | 175 | 0.75 | 0.75 |
−487T>C | rs2672598 | – | 109 | 67 | 10 | 162 | 31 | 2 | 97 | 68 | 18 | 0.23 | 0.13 |
c.34delCinsTCCT | Novel | L12insS | 0 | 5 | 183 | 0 | 2 | 193 | 0 | 16 | 167 | 2.90 × 10−2 | 3.10 × 10−2 |
c.59C>T | Novel | A20V | 7 | 30 | 148 | 3 | 42 | 150 | 2 | 56 | 125 | 3.70 × 10−3 | 0.01 |
c.102C>T | rs1049331 | A34A | 70 | 84 | 33 | 108 | 64 | 23 | 38 | 90 | 55 | 1.00 × 10−4 | 9.43 × 10−4 |
c.108G>T | rs2293870 | G36G | 70 | 84 | 33 | 108 | 64 | 23 | 38 | 90 | 55 | 1.00 × 10−4 | 9.43 × 10−4 |
c.IVS1-176C>G | rs12267142 | – | 0 | 17 | 170 | 0 | 19 | 176 | 0 | 25 | 158 | 0.17 | 0.18 |
c.569G>A | Novel | R190H | 0 | 1 | 186 | 0 | 0 | 195 | 0 | 0 | 183 | 1.00 | 1.00 |
c.IVS2+100C>T | rs80158665 | – | 0 | 4 | 183 | 0 | 4 | 191 | 0 | 8 | 175 | 0.23 | 0.23 |
c.IVS2+216A>G | Reported | – | 0 | 1 | 186 | 0 | 0 | 195 | 0 | 1 | 182 | 1.00 | 1.00 |
c.IVS2+317C>T | Reported | – | 0 | 2 | 185 | 0 | 2 | 193 | 0 | 1 | 182 | 1.00 | 1.00 |
c.672C>T | Novel | N224N | 0 | 1 | 186 | 0 | 0 | 195 | 0 | 0 | 183 | 1.00 | 1.00 |
IVS3+93C>T | rs2239586 | – | 30 | 73 | 84 | 19 | 89 | 87 | 22 | 92 | 69 | 0.09 | 0.65 |
IVS3+167G>A | rs2239587 | – | 30 | 73 | 84 | 19 | 89 | 87 | 22 | 92 | 69 | 0.09 | 0.65 |
IVS4+99C>T | rs2672582 | – | 38 | 76 | 73 | 35 | 105 | 55 | 30 | 86 | 67 | 0.41 | 0.85 |
IVS5+76_79delGTTT | Reported | – | 7 | 56 | 124 | 0 | 69 | 126 | 0 | 48 | 135 | – | – |
IVS5+169G>A | rs2672583 | – | 39 | 77 | 71 | 38 | 105 | 52 | 28 | 87 | 68 | 0.30 | 0.51 |
IVS6+58C>T | Novel | 0 | 1 | 186 | 0 | 0 | 195 | 0 | 0 | 183 | 1.00 | .001 | |
IVS6+111G>A | rs79778361 | – | 2 | 42 | 144 | 5 | 39 | 151 | 1 | 57 | 125 | – | – |
IVS6+115C>G | rs2672585 | – | 39 | 77 | 72 | 33 | 107 | 55 | 28 | 88 | 67 | 0.27 | 0.60 |
IVS7+149C>G | rs76357476 | – | 2 | 43 | 143 | 5 | 40 | 150 | 1 | 57 | 125 | – | – |
c.1221C>T | rs11538140 | D407D | 0 | 3 | 184 | 0 | 3 | 192 | 0 | 5 | 178 | 0.46 | 0.50 |
IVS8+14G>A | rs2272599 | – | 71 | 76 | 40 | 53 | 107 | 35 | 67 | 85 | 31 | 0.42 | 0.67 |
IVS8−36C>T | rs2293871 | – | 34 | 81 | 73 | 28 | 90 | 77 | 24 | 102 | 57 | – | – |
pG = genotypic p-value for PCV; pA = allelic p-value for PCV. The genotypic distribution was presented as homozygous/heterozygous/wild type. The rare variants in PCV (R190H) and exudative AMD (R59P, V417I) did not showed significant association either in single marker or grouped analysis.